Dose-Escalation Study of GSK2126458
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumours
Related studies linked through entity extraction aliases.
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
AZD1152 in Patients With Advanced Solid Malignancies-Study 3
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Ispinesib In Combination With Carboplatin In Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1